Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2020 Sep 16;8(2):e000381corr1. doi: 10.1136/jitc-2019-000381corr1

Correction: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

PMCID: PMC7497552  PMID: 32938626

Bai X, Wu D, Ma S, et al. Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study. J Immunothera Cancer 2020;8:e000381. doi: 10.1136/jitc-2019-000381

Since the online publication of this article, the authors have noticed that the word ‘study’ in the title was missing the last letter 'y'. The correct title is ‘Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study’ and has been updated in the article. Additionally, the tables were in the incorrect order in the article.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES